Safety and Efficacy Study in Non-Responder Hepatitis C Genotype 1 Patients With PHN121.

Trial Profile

Safety and Efficacy Study in Non-Responder Hepatitis C Genotype 1 Patients With PHN121.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 25 Nov 2013

At a glance

  • Drugs PHN 121 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Acronyms ENCHAMP
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 24 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top